Therefore, the current study aimed to test the hypothesis that LXA4 and its analog can alleviate LPS-induced inflammation in NHEKs and IMQ-induced psoriasiform dermatitis by preventing the expression and translocation of HMGB1. Here, HMGB1 is linked to Psoriasiform dermatitis.